Clinical Study
Performance of a New HPV Cervi-Collect Collection and Transportation Kit
Table 2
Correlations between Abbott RealTime HR HPV and Hybrid Capture 2 with PreservCyt L-Pap Samples.
| |||||||||||||||||||||||||||
Positive agreement—79.3% (73/92); Negative agreement—84.4% (103/122); Overall agreement—90.3% (176/195) (kappa = 0.80). |